1 active not recruiting, 1 not yet recruiting, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
Follow Cardiac Dysfunction: new trials by email Literature Review of Cardiac Dysfunction trials Research Report on Cardiac Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide Placebo, Nicotinamide Adenine Dinucleotide - Cardiac Dysfunction | Phase 2 | Not yet recruiting | Beijing Children's Hospital | 180 | 2026-10-01 | 2026-09-24 |
| A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction Vericiguat, Optimal medical therapy - Breast Cancer, Cardiac Dysfunction | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 21 | 2023-07-17 | 2026-08-03 |
| Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). Pemziviptadil (PB1046), Low Dose (10 mg) Control - Acute Respiratory Distress Syndrome, Coronavirus | Phase 2 | Terminated | PhaseBio Pharmaceuticals Inc. | 54 | 2020-07-15 | 2020-12-11 |
Breast Neoplasms (1) · COVID-19 (1) · Cardiovascular Diseases (1) · Coronavirus Infections (1) · Cytokine Release Syndrome (1) · Dyspnea (1) · Heart Failure (1) · Myocardial Infarction (1) · Pneumonia (1) · Pulmonary Edema (1) · Respiratory Distress Syndrome (1) · Respiratory Insufficiency (1)
Breast Diseases (1) · Coronaviridae Infections (1) · Heart Diseases (1) · Infarction (1) · Infections (1) · Inflammation (1) · Ischemia (1) · Lung Diseases (1) · Myocardial Ischemia (1) · Necrosis (1) · Neoplasms (1) · Neoplasms by Site (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
NAD (1) · Saline Solution (1) · Sodium Chloride (1) · VIP-ELP fusion molecule PB1046 (1) · vericiguat (1)
Beijing Children's Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · PhaseBio Pharmaceuticals Inc. (1)
United States (2) · China (1)